Sera Prognostics, Inc.
SERANASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $102.47M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.56$3.95
- Volume (live)
- -
- Avg. volume (3M)
- 16.14K
Sera Prognostics (SERA) Stock Price & Financial Analysis
Sera Prognostics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.03 - $2.10 |
|---|---|
| 52-Week High | $3.95 |
| 52-Week Low | $1.56 |
| Open | $2.04 |
| Volume (last close) | 25.03K |
| Average Volume (3M) | 16.14K |
| Revenue (TTM) | 70.00K |
|---|---|
| Net Income (TTM) | -33.23M |
| Free Cash Flow (TTM) | -28.18M |
| EPS (TTM) | −$0.66 |
| Profit Margin | -47475.71% |
| Operating Margin | -53282.86% |
| Return on Equity (ROE) | -55.97% |
| Debt to Equity | 0.05 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 102.47M |
|---|---|
| Shares Outstanding | 50.48M |
| Price to Sales (P/S) | 1463.83 |
| Price to Book (P/B) | 1.73 |
| EV/EBITDA | -3.14 |
| 50-Day MA | $2.05 |
|---|---|
| 200-Day MA | $2.19 |
| 1-Year Change | −39.10% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Sera Prognostics at a Glance
As of the Oct 23, 2026 close, Sera Prognostics (SERA) has a market capitalization of $102.47M. The stock trades at 1463.8× sales. Over the trailing twelve months it lost $33.23M on revenue of $70.00K and burned $28.18M of free cash flow. Revenue fell 35.2% year over year.
As of its latest reported balance sheet, it holds $4.40M in cash and securities against $3.00M of debt, a net cash position of $1.40M.
Sera Prognostics does not currently pay a dividend.
The share price is down 39.1% over the past year. At $2.03 (the Oct 23, 2026 close) it sits within its 52-week range of $1.56 to $3.95, below its 200-day moving average of $2.19.
Frequently Asked Questions About Sera Prognostics
What is the current stock price for SERA?
As of the Oct 23, 2026 close, SERA stock trades at $2.03. The 52-week range is $1.56–$3.95, with a day range of $2.03–$2.10.
What is the P/E ratio for SERA?
The P/E ratio (Price-to-Earnings) for SERA is shown in the Key Statistics section. This valuation metric helps compare Sera Prognostics, Inc. to industry peers.
Does SERA pay dividends?
Sera Prognostics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SERA?
Analyst ratings and recommendations for SERA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of SERA?
As of the Oct 23, 2026 close, Sera Prognostics's market capitalization is $102.5M, classifying it as a micro-cap company. Sera Prognostics operates in the Healthcare sector within the Medical Devices industry.